WallStreetZenWallStreetZen

NASDAQ: NRIX
Nurix Therapeutics Inc Stock Ownership - Who owns Nurix Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nurix Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gwenn HansenCSci2026-08-054,356$1.86
$8.10kBuy
Gwenn HansenCSci2026-08-054,356$25.00
$108.90kSell
Gwenn HansenCSci2026-08-041,500$23.87
$35.80kSell
Gwenn HansenCSci2026-08-042,611$24.64
$64.34kSell
Houte Hans VanCFO2026-08-042,967$24.65
$73.13kSell
Houte Hans VanCFO2026-08-041,794$23.89
$42.86kSell
Christine RingCLO2026-08-0316,589$23.05
$382.36kSell
Christine RingCLO2026-08-035,787$8.72
$50.46kBuy
Christine RingCLO2026-07-303,847$23.38
$89.95kSell
Houte Hans VanCFO2026-07-302,845$23.38
$66.52kSell

1 of 5

NRIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRIX insiders and whales buy or sell their stock.

NRIX Shareholders

What type of owners hold Nurix Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Third Rock Ventures III LP3.38%3,509,348$94.51MInsider
Column Group L P2.00%2,080,607$56.03MInsider
Redmile Group LLC1.13%1,176,470$31.68MInsider
Wellington Biomedical Innovation Master Investors Cayman I LP0.76%784,313$21.12MInsider
Arthur T. Sands0.44%458,333$12.34MInsider
Robert Tjian0.12%124,999$3.37MInsider
Pierre Beaurang0.12%120,996$3.26MInsider
Gwenn Hansen0.11%117,227$3.16MInsider
Houte Hans Van0.04%40,166$1.08MInsider
David L. Lacey0.03%33,333$897.66kInsider

1 of 3

NRIX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRIX0.11%8.16%Net SellingNet Selling
VRDN0.12%32.00%Net BuyingNet Buying
SLS0.04%5.15%Net Selling
ZLAB0.00%1.78%Net BuyingNet Selling
BEAM0.11%16.19%Net SellingNet Selling
View Top Biotech Stocks

Nurix Therapeutics Stock Ownership FAQ

Who owns Nurix Therapeutics?

Nurix Therapeutics (NASDAQ: NRIX) is owned by 0.11% institutional shareholders, 8.16% Nurix Therapeutics insiders, and 91.72% retail investors. Third Rock Ventures III LP is the largest individual Nurix Therapeutics shareholder, owning 3.51M shares representing 3.38% of the company. Third Rock Ventures III LP's Nurix Therapeutics shares are currently valued at $97.52M.

If you're new to stock investing, here's how to buy Nurix Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.